JENKEM

Zhitong · Oct 15, 2025 at 03:01 AM

JENKEM: Currently, the applicable U.S. tariff rate for the company's products has not changed

Zhitong · Sep 9, 2025 at 01:19 AM

A-share innovative drug concept stocks fluctuated lower, with InventisBio falling over 10%. Other stocks such as Huahai Pharmaceutical, JENKEM, Lifeon Pharmaceutical, JOINN, Guangsheng Tang, HitGen, and Baillie Gifford also dropped more than 6%

Zhitong · Sep 8, 2025 at 06:19 AM

JENKEM: Wu Kaiting plans to reduce his holdings by no more than 2%

Zhitong · Sep 3, 2025 at 08:41 PM

Innovative drug concept stocks are repeatedly active, Chimin hits the daily limit

Zhitong · Sep 2, 2025 at 02:36 AM

JENKEM: Actively exploring the optimization of existing R&D processes through AI

Zhitong · Aug 28, 2025 at 06:34 AM

JENKEM released its semi-annual performance, with a net profit attributable to the parent company of 22.05 million yuan, a year-on-year decrease of 21.08%